Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.

作者: P Hinds , C Finlay , A J Levine

DOI: 10.1128/JVI.63.2.739-746.1989

关键词: BiologyProto-Oncogene Proteins p21(ras)Complementary DNATransfectionOncogeneTransformation (genetics)MutationGeneMolecular biologyClone (cell biology)

摘要: Previous experiments have brought into question which amino acid sequence of the p53 oncogene product should be considered wild type and whether normal protein is capable cooperating with ras to transform cells in culture. To address these questions, a series cDNA-genomic hybrid clones been compared for ability cooperate transformation assays. From experiments, it has become clear that alanine at position 135, either genomic clone or cDNA clone, failed produce cooperated transformed cells. Replacing valine this activated assay. Using restriction enzyme polymorphisms gene, was shown mouse DNA encodes 135 protein. Thus, mutation required activate cooperation oncogene. After cotransfection always produced more cell foci (1.7-fold) than similar were readily cloned (3.6-fold) permanent lines. A deletion mutants employed show presence intron 4 gene sufficient provide much enhanced clonability from culture dishes. The introns constructions also resulted elevated levels p53-plus-ras-transformed qualitative changes are ras. Quantitative improvements frequencies associated higher expression altered provided by having one transforming plasmid.

参考文章(29)
B. Bienz, R. Zakut-Houri, D. Givol, M. Oren, Analysis of the gene coding for the murine cellular tumour antigen p53. The EMBO Journal. ,vol. 3, pp. 2179- 2183 ,(1984) , 10.1002/J.1460-2075.1984.TB02110.X
Allan M. Maxam, Walter Gilbert, [57] Sequencing end-labeled DNA with base-specific chemical cleavages Nucleic Acids Part I. ,vol. 65, pp. 499- 560 ,(1980) , 10.1016/S0076-6879(80)65059-9
V Rotter, O N Witte, R Coffman, D Baltimore, Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50. Journal of Virology. ,vol. 36, pp. 547- 555 ,(1980) , 10.1128/JVI.36.2.547-555.1980
N Arai, D Nomura, K Yokota, D Wolf, E Brill, O Shohat, V Rotter, Immunologically distinct p53 molecules generated by alternative splicing. Molecular and Cellular Biology. ,vol. 6, pp. 3232- 3239 ,(1986) , 10.1128/MCB.6.9.3232
C A Finlay, P W Hinds, T H Tan, D Eliyahu, M Oren, A J Levine, Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Molecular and Cellular Biology. ,vol. 8, pp. 531- 539 ,(1988) , 10.1128/MCB.8.2.531
N C Reich, M Oren, A J Levine, Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Molecular and Cellular Biology. ,vol. 3, pp. 2143- 2150 ,(1983) , 10.1128/MCB.3.12.2143
P W Hinds, C A Finlay, A B Frey, A J Levine, Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Molecular and Cellular Biology. ,vol. 7, pp. 2863- 2869 ,(1987) , 10.1128/MCB.7.8.2863
Mitchell Goldfarb, Kenji Shimizu, Manuel Perucho, Michael Wigler, Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells Nature. ,vol. 296, pp. 404- 409 ,(1982) , 10.1038/296404A0
Rina Zakut-Houri, Moshe Oren, Brigitta Bienz, Vered Lavie, Shula Hazum, David Givol, A single gene and a pseudogene for the cellular tumour antigen p53 Nature. ,vol. 306, pp. 594- 597 ,(1983) , 10.1038/306594A0